AstraZeneca has exercised an option to license a cell therapy from Quell Therapeutics, resulting in a $10m milestone payment ...
It highlights the strong commitment and rapid integration of our respective research teams as well as providing important early validation of our novel CAR-Treg cell therapy approach to autoimmune ...
Regenerative medicine has the potential to reshape how we treat diseases, offering new hope for patients requiring cell, ...
A University professor has found a new way to treat cancer using different cell compounds, like the NR0B2 protein.
While the human body’s immune system is generally able to defend against harmful germs, diseases like cancer are trickier to ...
Researchers collaborated on a novel, highly specific strategy to treat type 1 diabetes using a tagged beta cell transplant in ...
Researchers at the Medical University of South Carolina and the University of Florida recently collaborated on a novel, ...
Regenerative medicine holds the extraordinary promise that future patients in need of new cells, tissues or organs will no ...
LPX- TI641 is an oral novel Treg-expanding T cell/transmembrane, immunoglobulin, and mucin (Tim)receptor agonist therapy in development for the treatment of autoimmune diseases such as rheumatoid ...